恩赛特韦富马酸盐新

参考资料仅供科学研究，不可用于个人用途。

货号：BCP46193CAS号：2757470-18-9纯度：98%

规格	价格(CNY)	是否现货	购买咨询
10.00 mg	￥1200.00	In-stock	购买咨询
25.00 mg	￥1700.00	In-stock	购买咨询
50.00 mg	￥2500.00	In-stock	购买咨询

在线咨询

大批量询价

全国免运费！免费咨询：400-099-8200 或手机联系：13472751340

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS号	2757470-18-9	货号	BCP46193
中文名	恩赛特韦富马酸盐
英文名	Ensitrelvir fumarate
中文别名	S-217622富马酸盐;
英文别名	S-217622 fumarate; S 217622 fumarate; S217622 fumarate;
SMILES	CN1C=C2C=C(C(=CC2=N1)Cl)NC3=NC(=O)N(C(=O)N3CC4=CC(=C(C=C4F)F)F)CC5=NN(C=N5)C.C(=CC(=O)O)C(=O)O
化学名称
分子式	C26H21ClF3N9O6	分子量	647.96
纯度	98%	配送	惯例下常温包邮
产品描述	Ensitrelvir, also known as S-217622, is an antiviral drug developed by Shionogi in partnership with Hokkaido University, which acts as an orally active 3C-like protease inhibitor for the treatment of COVID-19 infection. It is taken by mouth, and has been successfully tested against the recently emerged Omicron variant. It is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM). It became the first Japanese domestic pill to treat COVID-19, third to be regulatorally approved in Japan; in February 2022.

恩赛特韦富马酸盐 新